Healthcare - Biotechnology - NASDAQ - US
$ 6.8
-3.13 %
$ 1.88 B
Market Cap
85.0
P/E
Price Target
Average
76.47%
Revenue Forecast
Estimate
25.81%
EBIT
Estimate
--140.27%
Net Income
Estimate
93.89%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
MannKind Corporation
Wall Street analysts predict an average 1-year price target for MNKD of $12 , with forecasts ranging from a low of $12 to a high of $12 .
MNKD Lowest Price Target
Wall Street Target
12 USD
76.47%
MNKD Average Price Target
Wall Street Target
12 USD
76.47%
MNKD Highest Price Target
Wall Street Target
12 USD
76.47%
REVENUE FORECAST
Revenue Forecast Chart MNKD
EBIT FORECAST
EBIT Forecast Chart MNKD
NET INCOME FORECAST
Net Income Chart MNKD